Related references
Note: Only part of the references are listed.
Article
Ophthalmology
Sai Bhakti Mishra et al.
Summary: This article presents a rare case of varicella zoster infection following COVID-19 vaccination in an elderly Asian Indian male. The findings suggest a possible link between COVID-19 vaccine and viral reactivation, particularly in elderly individuals with comorbidities.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
(2023)
Editorial Material
Ophthalmology
Atul Arora et al.
Summary: This study reports the recurrence of tubercular choroiditis in two patients with quiescent disease activity for more than a year following anti-SARS-CoV-2 vaccination. The findings suggest a potential role of vaccination as a trigger for disease reactivation.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
(2023)
Letter
Ophthalmology
Melanie Hebert et al.
Summary: This case report describes a patient who developed bilateral panuveitis and occlusive vasculitis following COVID-19 vaccination. The patient showed improvement with topical and systemic corticosteroid treatment. This report highlights the importance of considering vaccine adverse reactions in the differential diagnosis of ocular presentations.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2023)
Article
Ophthalmology
Ha Eun Sim et al.
Summary: This study presents 11 cases of new-onset acute uveitis following COVID-19 vaccination. The uveitis responded well to steroid therapy, with no visual impairment observed.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
(2023)
Article
Ophthalmology
Felipe de Queiroz Tavares Ferreira et al.
Summary: This article reports a possible association between VKH disease and SARS-CoV-2 vaccination, with two cases presenting symptoms within 1 or 2 weeks after receiving the ChAdOx1 nCoV-19 vaccine, one case experiencing symptoms 5 days after receiving the BNT162b2 vaccine, and one case developing symptoms within 4 weeks after receiving the CoronaVac vaccine. Early diagnosis and treatment are crucial for the visual prognosis of this aggressive disease.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2023)
Article
Ophthalmology
Junhong Ren et al.
Summary: A four-case series of ocular adverse events post inactivated COVID-19 vaccination in China is reported. The ocular inflammatory reactions in these patients were resolved with corticosteroid treatment and were considered to be inflammatory reactions caused by the SARS-CoV-2 vaccine.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2023)
Article
Ophthalmology
Shai Cohen et al.
Summary: Herpetic ocular infections may occur shortly after SARS-CoV-2 vaccinations, with varicella zoster virus (VZV) and herpes simplex virus (HSV) being the most common infections. Most cases occur after the first vaccine dose, but some may occur after the second or third dose. The most common presentations are herpes zoster ophthalmicus (HZO) with ocular involvement and HSV keratitis, with good overall outcomes.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2023)
Review
Immunology
Yue Chen et al.
Summary: Autoimmune manifestations have been reported in response to certain COVID-19 vaccines, but it is still unclear whether there is a causal relationship. These reports can help guide the clinical assessment and management of autoimmune manifestations after vaccination.
Article
Ophthalmology
Yogya Reddy et al.
Summary: This study observed a direct correlation between the Covishield vaccine and Harada-like syndrome, suggesting that the vaccination may trigger a flare-up of ocular disease.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2022)
Article
Rheumatology
Athanasios Sachinidis et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
(2022)
Article
Ophthalmology
Sang Yoon Kim et al.
Summary: This article reports a case of bilateral panuveitis in a 72-year-old woman after receiving the first dose of a SARS-CoV-2 vaccine. The resolution of panuveitis was observed through multimodal retinal imaging. Systemic steroid therapy effectively alleviated inflammation in the eyes and meninges, with no recurrence observed.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Letter
Ophthalmology
Jean-Baptiste Brunet de Courssou et al.
Summary: A 57-year-old female developed Vogt-Koyanagi-Harada (VKH) disease 3 weeks after receiving a Covid-19 mRNA vaccine. Pharmacovigilance study revealed disproportionate reporting of VKH disease with tozinameran and other vaccines. Cases suggest a possible safety signal for VKH disease after vaccination.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Article
Immunology
Rumeysa Yalcinkaya et al.
Summary: This article presents a case of a 12-year-old boy who developed MIS-C after receiving his first dose of the COVID-19 mRNA vaccine, despite having no prior COVID-19 infection or exposure. It is rare to report cases of MIS-C following COVID-19 vaccination, with most cases occurring in adults.
PEDIATRIC INFECTIOUS DISEASE JOURNAL
(2022)
Article
Medicine, General & Internal
Kunpeng Pang et al.
Summary: This study reported cases of ocular adverse reactions following COVID-19 vaccination, including choroiditis, uveitis, keratitis, etc. Although the causal relationship between vaccines and ocular adverse events cannot be established, physicians should pay attention to this phenomenon.
FRONTIERS IN MEDICINE
(2022)
Article
Ophthalmology
Ilaria Testi et al.
Summary: This study investigates ocular inflammatory events following COVID-19 vaccination and finds that most events are mild and do not significantly affect vision.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
(2022)
Article
Brian A. Lee et al.
Retinal Cases and Brief Reports
(2022)
Article
Ophthalmology
B. Gedik et al.
Summary: This case report presents a patient who developed both eye and skin side effects after receiving the Pfizer-BioNTech vaccine, including eye pain, reduced vision, redness, and a morbilliform rash.
JOURNAL FRANCAIS D OPHTALMOLOGIE
(2022)
Article
Ophthalmology
Konstantinos I. Rallis et al.
Summary: This study retrospectively analyzed patients who developed herpetic eye disease (HED) within 28 days after receiving the COVID-19 vaccine. The findings suggest a potential association between COVID-19 vaccination and HED. Prophylactic antiviral treatment is recommended for patients with a history of HED before vaccination.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Letter
Ophthalmology
Rohini Sangoram et al.
Summary: This case report describes an incidence of HSV 1 anterior uveitis following COVID-19 vaccination. A viral etiology should be considered when ocular symptoms occur after vaccination.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Letter
Ophthalmology
Afshan A. Nanji et al.
Summary: This article presents two cases of anterior uveitis following Moderna COVID-19 vaccination and summarizes reports from the World Health Organization global database. Based on the temporal pattern in these cases, there may be an association between uveitis and COVID-19 vaccination.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Letter
Ophthalmology
Chan Woong Joo et al.
Summary: This study reports a case of VKH disease following mRNA-1273 (Moderna) COVID-19 vaccination. The patient developed bilateral serous retinal detachment 35 days after the first dose and experienced adverse effects such as erythema and pain at the injection site, headache, myalgia, and allergy symptoms. Treatment with oral prednisolone resulted in resolution of the retinal detachment and improved vision.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Letter
Ophthalmology
Nawfel Ferrand et al.
Summary: This study retrospectively reviewed the epidemiological and clinical features of uveitis after COVID-19 vaccination and found that COVID-19 vaccination can cause uveitis but has no significant impact on visual prognosis.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Article
Ophthalmology
Massimo Accorinti et al.
Summary: This article reports a relapse of Vogt-Koyanagi-Harada (VKH) disease in a patient after COVID-19 vaccination. The patient experienced a relapse of uveitis eleven days after the first vaccination, but achieved complete recovery through classic VKH therapy. Despite immunosuppressive treatment, the patient still had an immune response to the vaccine.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Article
Ophthalmology
Jayanti Singh et al.
Summary: This article reports a case of herpes simplex virus retinitis following COVISHIELD vaccination. Extensive investigations ruled out infectious etiology except for positive PCR for herpes simplex virus in vitreous specimen. The patient responded well to treatment.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Article
Cell Biology
Begona De Domingo et al.
Summary: We present a case of exacerbation of Vogt-Koyanagi-Harada (VKH) disease following COVID-19 vaccination. A 46-year-old woman developed bilateral granulomatous uveitis after the first dose of COVID-19 mRNA vaccine (Comirnaty, Pfizer-BioNTech), and was diagnosed with complete VKH disease four days after receiving the second dose. The symptoms were successfully treated with high dose intravenous corticosteroids, followed by oral prednisone. The close temporal relationship between COVID-19 vaccination and exacerbation of VKH symptoms strongly suggests a causal link.
Article
Immunology
Xiuju Chen et al.
Summary: This case series reported potential ocular adverse events following inactivated COVID-19 vaccination. Some patients developed inflammation and other symptoms in their eyes, but the symptoms were relieved after steroid treatment and there was no recurrence.
Review
Immunology
Xinyi Ding et al.
Summary: Ocular complications, including VKH disease, may occur after COVID-19 vaccination, although the causality is unclear. Doctors should be aware and inform patients about the possible ocular adverse effects.
Review
Medicine, General & Internal
Abdul-Wahab Al-Allaf et al.
Summary: This article presents a case of a middle-aged man who developed vasculitis involving the celiac trunk and its branches, and acute anterior uveitis after receiving the Pfizer BioNTech COVID-19 vaccine. It highlights the need for further research to establish an association between the COVID-19 vaccine and these immunologic phenomena.
ANNALS OF MEDICINE AND SURGERY
(2022)
Article
Ophthalmology
Padmamalini Mahendradas et al.
Summary: This case report highlights the potential risk of exacerbation of uveitis with posterior segment manifestations following anti-SARS-CoV-2 vaccination in patients with JIA-associated uveitis.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
(2022)
Article
Ophthalmology
Je Hyung Hwang
Summary: This report describes a case of acute uveitis following COVID-19 vaccination. The patient showed improvement after treatment.
CASE REPORTS IN OPHTHALMOLOGY
(2022)
Article
Medicine, General & Internal
Jose Manuel Ortiz-Egea et al.
Summary: Two cases of herpetic anterior uveitis following Pfizer-BioNTech coronavirus disease 2019 vaccination are reported. Both patients recovered with antiviral treatment.
JOURNAL OF MEDICAL CASE REPORTS
(2022)
Article
Asaf Achiron et al.
American Journal of Ophthalmology Case Reports
(2022)
Article
Xiuju Chen et al.
American Journal of Ophthalmology Case Reports
(2022)
Article
Eriko Yasuda et al.
American Journal of Ophthalmology Case Reports
(2022)
Letter
Ophthalmology
M. Duran
JOURNAL FRANCAIS D OPHTALMOLOGIE
(2022)
Article
Ophthalmology
Kishan G. Patel et al.
Summary: This study presents four cases of posterior ophthalmic manifestations associated with SARS-CoV-2 vaccination, including uveitis, maculopathy, and optic neuropathy. The clinical courses of these cases varied, suggesting a possible association between vaccination and posterior ophthalmic manifestations.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2022)
Article
Medicine, General & Internal
Mihyun Choi et al.
Summary: A retrospective observational case series was conducted to study ophthalmic manifestations in patients after COVID-19 vaccination. Various ocular symptoms were observed, including retinal vein occlusion, retinal artery occlusion, anterior uveitis, exacerbation of panuveitis, and angle-closure attack. However, a causal relationship between vaccination and ocular manifestations could not be determined.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Immunology
Cyril N. A. Nyankerh et al.
Summary: This study investigated ocular adverse events following COVID-19 vaccination. The analysis found that eyelid swelling, ocular hyperemia, and conjunctivitis were the most common side effects. Females and individuals aged 40-59 had a higher risk of experiencing these adverse events. Patients with pre-existing conditions such as allergies, hypertension, diabetes, thyroid disease, vascular, and autoimmune diseases were more likely to develop ocular adverse events.
Article
Immunology
Zhihua Li et al.
Summary: This study reports the clinical characteristics of ocular adverse events that occurred in China after vaccination with inactivated COVID-19 vaccines. The results indicate that there is no established relationship between inactivated COVID-19 vaccines and ocular disorders. Further investigation of the clinical spectrum is necessary.
Article
Medicine, General & Internal
Milton C. Chew et al.
Summary: This study reported cases of uveitis after COVID-19 vaccination and booster in Singapore. They found a higher rate of reactivations of latent infections. With definitive treatment, all cases resolved without systemic sequelae. Prophylactic treatment during booster vaccine may help prevent the recurrence of sight-threatening infections.
FRONTIERS IN MEDICINE
(2022)
Article
Rheumatology
Saskia Lawson-Tovey et al.
Summary: This study investigates the safety of SARS-CoV-2 vaccination in adolescents with inflammatory rheumatic diseases and adults with juvenile idiopathic arthritis. The results show a low frequency of disease flares and adverse events in both populations after vaccination.
Article
Ophthalmology
Snezhana Murgova et al.
Summary: This report describes ocular side effects in patients who received Astra Zeneca or Pfizer-Biontech COVID-19 vaccines and aims to contribute to the understanding of the vaccination process. The results show that some patients developed underlying herpetic disease, uveitis, keratitis, thrombosis, and optic neuropathy after vaccination.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
(2022)
Article
Medicine, General & Internal
Tadahisa Numakura et al.
Summary: This article reports a case of novel sarcoidosis development after BNT162b2 vaccination and reviews other similar reactions reported.
Article
Ophthalmology
Rohan Bir Singh et al.
Summary: This study aims to assess the risk of vaccine-associated uveitis (VAU) after SARS-CoV-2 vaccination and found a low incidence of VAU for the BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines. Further investigations are needed to understand the underlying immunological mechanisms.
Article
Immunology
Rohan Bir Singh et al.
Summary: This study retrospectively analyzed cases of glaucoma following SARS-CoV-2 vaccination and found that the incidence of glaucoma was extremely rare. Most cases were reported within the first week of vaccination, and they were more common in female patients and those in their fifties to seventies. There may be a higher risk of glaucoma associated with the BNT162b2 vaccine.
Article
Chiaki Yamaguchi et al.
American Journal of Ophthalmology Case Reports
(2022)
Article
Chaeyeon Lee et al.
American Journal of Ophthalmology Case Reports
(2022)
Article
Rheumatology
Ayse Ozdede et al.
Summary: This study investigated the side effects and disease flares after COVID-19 vaccination in patients with Behcet's syndrome (BS), familial Mediterranean fever (FMF), and rheumatic diseases (RD), who were vaccinated with Pfizer/BioNTech or Sinovac/CoronaVac. The study found that BioNTech had better efficacy against COVID-19 in all patient groups compared to CoronaVac, but the frequency of adverse events (AE) was higher with BioNTech. Most AEs were mild to moderate and transient. There were also AEs that required medical attention, mainly due to disease flares and cardiovascular events. BS and FMF patients had significantly higher flare rates, which may indicate defects in innate immunity. Therefore, caution should be exercised in monitoring these patients after vaccination.
RHEUMATOLOGY INTERNATIONAL
(2022)
Article
Ophthalmology
Peeyusha D. Kakarla et al.
Summary: This case report highlights a case of uveitis following COVID-19 vaccination, which is usually benign, transient, and results in excellent outcomes with timely diagnosis and early treatment.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2022)
Article
Ophthalmology
Ioannis Papasavvas et al.
Summary: VKH disease is a primary stromal choroiditis with bilateral granulomatous panuveitis that can be controlled with early and sustained immunosuppressive treatment. However, this case report highlights a patient who experienced disease reactivation after receiving the second dose of an anti-SARS-CoV-2 vaccination.
JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION
(2021)
Meeting Abstract
Critical Care Medicine
Juan Santiago et al.
Article
Immunology
Yuval Ishay et al.
Summary: Vaccines are seen as a potential solution to the COVID-19 pandemic, but widespread distribution has been hindered by concerns over side effects. In Israel, where a large percentage of the population has been vaccinated, cases of autoimmune conditions following vaccination have been observed, but they generally have mild symptoms requiring modest treatment.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2021)
Article
Infectious Diseases
Lijie Pan et al.
Summary: A 50-year-old woman developed bilateral posterior uveitis 5 days after receiving the COVID-19 vaccine, which significantly improved with steroid treatment. This case suggests that uveitis following vaccination is usually transient and responds well to steroids.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Elena Bolletta et al.
Summary: The study reports cases of uveitis and other ocular complications following COVID-19 vaccination, with various eye conditions observed. The onset of these complications occurred on average 9.4 days after vaccination.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Health Care Sciences & Services
Lina Wang et al.
Summary: Uveitis, a common and potentially sight-threatening intraocular inflammatory disorder, has a significant impact on visual acuity. Early diagnosis and effective treatment are essential to reduce complications and protect vision. Detailed clinical examination, laboratory tests, and appropriate treatment are crucial in managing uveitis and preventing ocular complications.
ANNALS OF PALLIATIVE MEDICINE
(2021)
Article
Infectious Diseases
Giulia Renisi et al.
Summary: A 23-year-old male developed anterior uveitis 14 days after receiving the second dose of BNT162b2 COVID-19 vaccine. Symptoms improved after a 10-day treatment course of topical steroids and cycloplegic eye drops, indicating a potential association between SARS-CoV-2 vaccination and eye inflammation.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Multidisciplinary Sciences
Valerie Oberhardt et al.
Summary: After vaccination, CD8(+) T cells become important effector cells in providing early protection, being effectively mobilized one week after primary vaccination and maintaining stability after booster vaccination. Compared with natural infection, vaccine-induced CD8(+) T cells exhibit similar functional capacities but with a different subset distribution.
Article
Medicine, General & Internal
Noam Barda et al.
Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Letter
Ophthalmology
Mallika Goyal et al.
Summary: This case report highlights a rare occurrence of bilateral choroiditis following COVID-19 vaccination, suggesting an inflammatory or autoimmune response. Prompt diagnosis and treatment with corticosteroids can lead to rapid improvement in visual outcomes for patients experiencing ocular symptoms post-vaccination.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2021)
Article
Ophthalmology
Lucy I. Mudie et al.
Summary: This report describes a case of panuveitis following the Pfizer-Biotech mRNA COVID-19 vaccine, with improvement noted after treatment with corticosteroids but mild recurrence after drug tapering.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2021)
Letter
Ophthalmology
Reem H. ElSheikh et al.
Summary: An 18-year-old girl developed bilateral anterior uveitis 5 days after receiving the Sinopharm COVID-19 vaccine. The uveitis in both eyes resolved gradually with topical steroid treatment without recurrence. This case report suggests a potential causal association between COVID-19 vaccine and anterior uveitis.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2021)
Letter
Ophthalmology
Lin Ru Koong et al.
Summary: A 54-year-old Chinese male without prior ocular history presented to the ophthalmology department with bilateral acute painless blurring of vision after receiving the COVID-19 mRNA vaccine. Clinical examination and imaging tests confirmed Vogt-Koyanagi-Hara disease, and the patient responded well to treatment with high-dose intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2021)
Article
Ophthalmology
Tamar Rabinovitch et al.
Summary: This study describes uveitis cases following the administration of the BNT162b2 mRNA vaccine. Most cases presented as mild to moderate anterior uveitis, with a few developing multiple evanescent white dot syndrome.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
(2021)
Letter
Ophthalmology
Aarti Jain et al.
INDIAN JOURNAL OF OPHTHALMOLOGY
(2021)
Article
Ophthalmology
Janaina Jamile Ferreira Saraceno et al.
Summary: The challenge of COVID-19 has brought significant changes to global medical management, leading to a rapid development of vaccines. This study presents two cases of VKH syndrome following SARS-CoV-2 vaccination, suggesting a potential causal relationship between COVID-19 and uveitis.
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS
(2021)
Review
Public, Environmental & Occupational Health
Taulant Muka et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY
(2020)
Article
Multidisciplinary Sciences
Ugur Sahin et al.
Editorial Material
Ophthalmology
Emmett T. Cunningham et al.
OCULAR IMMUNOLOGY AND INFLAMMATION
(2019)
Review
Immunology
Ram Pyare Singh et al.
AUTOIMMUNITY REVIEWS
(2014)
Review
Ophthalmology
Maria M. Choudhary et al.
JOURNAL OF OPHTHALMOLOGY
(2014)
